Unconfigured Ad

Collapse

Sequencing by Oligo Ligation/Detection (Life Technologies)

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by ECO, 11-11-2007, 11:23 PM
63 responses
233,817 views
0 reactions
Last Post shahinda rezk  
Started by exprofiler, 09-22-2008, 08:10 AM
36 responses
56,559 views
0 reactions
Last Post ringo1230  
Started by JPC, 02-03-2012, 08:21 AM
4 responses
2,743 views
0 reactions
Last Post JPC
by JPC
 
Started by Pitch, 01-25-2012, 05:55 AM
5 responses
2,613 views
0 reactions
Last Post colindaven  
Started by colindaven, 04-19-2011, 06:53 AM
16 responses
7,518 views
0 reactions
Last Post RickC7
by RickC7
 
Started by Heisman, 01-26-2012, 07:55 PM
11 responses
5,641 views
0 reactions
Last Post Richard Finney  
Started by rkk, 12-22-2011, 03:17 PM
1 response
3,359 views
0 reactions
Last Post colindaven  
Started by sreeja, 01-11-2012, 11:02 PM
1 response
2,654 views
0 reactions
Last Post sciencegnome  
Started by relipmoc, 11-18-2011, 12:40 AM
1 response
2,443 views
0 reactions
Last Post Anelda
by Anelda
 
Started by paolo.kunder, 12-29-2011, 05:58 AM
5 responses
4,607 views
0 reactions
Last Post kevleb
by kevleb
 
Started by lre1234, 12-28-2011, 07:57 AM
1 response
2,450 views
0 reactions
Last Post Zaag
by Zaag
 
Started by ageliki, 12-22-2011, 04:18 PM
1 response
2,438 views
0 reactions
Last Post SeqAA
by SeqAA
 
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Working...